Congrats to lab member Neil Carleton and surgeon / lab collaborator Dr. Priscilla McAuliffe on their recent publication in Nature Reviews Clinical Oncology! This comment explores how chronological age cutoffs in clinical oncology guidelines are defined. Using the case of breast cancer in older women, the authors discuss why the age at which individuals transition from ‘younger’ to ‘older’ has been defined in a heterogeneous, unstandardized, arbitrary and disparate manner.
Read the full article here: https://www.nature.com/articles/s41571-022-00684-4.
Congratulations to Dr Sayali Onkar for successfully defending her PhD dissertation ‘Investigating the Immune Microenvironment of Primary Estrogen Receptor Positive Breast Cancer ‘. Sayali was co-mentored by Steffi Oesterreich, and Dario Vignali (immunology). Congrats, Dr Onkar!
The Lee/Oesterreich lab walked as the “Steel City Research Warriors” team in the 2022 Komen West Pennsylvania “More Than Pink” Walk.
Some of the Lee/Oesterreich lab toured our new lab space in the Ford Building to plan how we will set up the lab when we move this summer. The new building in Shadyside, where Model-T Ford cars used to be assembled, will allow closer integration with other research teams at the UPMC Hillman Cancer Center as well as offering an efficient and sleek design.
Adrian and Steffi meeting up with lab alumni at AACR April 2022.
Congratulations to Adrian and Steffi who were invited to attend the 2022 Pitt Faculty Honors Convocation Ceremony and received medals recognizing their distinguished accomplishments. Adrian received his medal for his position as the Pittsburgh Foundation Endowed Chair in Precision Medicine. Steffi received her medal for her position as the Shear Family Endowed Chair in Breast Cancer Research.
We are so happy to welcome new members of the larger Lee/Oesterreich lab family into the world. Congratulations Sayali and family, and Olivia and family!
Ashuvinee Elangovan, Ph.D. successfully convinced her committee that her project entitled “Loss of E-Cadherin Activates a Targetable IF1R Pathway in Invasive Lobular Breast Cancer” is worthy of a Philosophiae Doctor! Cheers to Ashu!!
Congrats to Vaciry Li for the feature in the Pitt School of Medicine Newsletter!